167 related articles for article (PubMed ID: 18985592)
1. [Preventive treatment of chronic migraine with zonisamide: a study in patients who are refractory or intolerant to topiramate].
Pascual-Gómez J; Alañá-García M; Oterino A; Leira R; Láinez-Andrés JM
Rev Neurol; 2008 Nov 1-15; 47(9):449-51. PubMed ID: 18985592
[TBL] [Abstract][Full Text] [Related]
2. [Zonisamide in the preventive treatment of refractory migraine].
Pascual-Gómez J; Gracia-Naya M; Leira R; Mateos V; Alvaro-González LC; Hernando I; Oterino A; Iglesias--Díez F; Caminero A; García-Moncó JC; Forcea N; Guerrero-Peral AL; Bueno V; Santos-García D; Pérez C; Blanco M; Pego-Reigosa R; Rodríguez R; Mederer-Hengstl S; Pato-Pato A; Sánchez-Herrero J; Maciñeiras-Montero JL; Ortega F; Arias M; Díaz-González M
Rev Neurol; 2010 Feb 1-15; 50(3):129-32. PubMed ID: 20146184
[TBL] [Abstract][Full Text] [Related]
3. Zonisamide for migraine prophylaxis in patients refractory to topiramate.
Bermejo PE; Dorado R
Clin Neuropharmacol; 2009; 32(2):103-6. PubMed ID: 18978487
[TBL] [Abstract][Full Text] [Related]
4. Zonisamide for migraine prophylaxis in topiramate-intolerant patients: an observational study.
Villani V; Ciuffoli A; Prosperini L; Sette G
Headache; 2011 Feb; 51(2):287-91. PubMed ID: 21284610
[TBL] [Abstract][Full Text] [Related]
5. Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trial.
Mohammadianinejad SE; Abbasi V; Sajedi SA; Majdinasab N; Abdollahi F; Hajmanouchehri R; Faraji A
Clin Neuropharmacol; 2011; 34(4):174-7. PubMed ID: 21738025
[TBL] [Abstract][Full Text] [Related]
6. [The role of the neuromodulators in the preventive treatment of migraine].
Pascual-Gómez J
Rev Neurol; 2009 Jul 1-15; 49(1):25-32. PubMed ID: 19557697
[TBL] [Abstract][Full Text] [Related]
7. [Low versus high doses of topiramate in the preventive treatment of migraine].
Cacabelos P; El Berdei Y; Rivas MT; Riveira C; Conde A; Pascual J
Neurologia; 2009 Nov; 24(9):808-10. PubMed ID: 20099154
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
[TBL] [Abstract][Full Text] [Related]
9. [Frequent episodic migraine and calcitonin gene-related peptide. Influence of treatment with topiramate and zonisamide on levels of the peptide].
Garcia-Estevez DA; Pardo-Parrado M; Silvarrey-Rodriguez S
Rev Neurol; 2017 Aug; 65(4):153-156. PubMed ID: 28726232
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate.
Mathew NT; Kailasam J; Meadors L
Headache; 2002 Sep; 42(8):796-803. PubMed ID: 12390644
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of zonisamide in migraineurs with nonresponse to topiramate.
Chung JY; Kim MW; Kim M
Biomed Res Int; 2014; 2014():891348. PubMed ID: 25101297
[TBL] [Abstract][Full Text] [Related]
12. Topiramate for migraine prevention: a randomized controlled trial.
Brandes JL; Saper JR; Diamond M; Couch JR; Lewis DW; Schmitt J; Neto W; Schwabe S; Jacobs D;
JAMA; 2004 Feb; 291(8):965-73. PubMed ID: 14982912
[TBL] [Abstract][Full Text] [Related]
13. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
Rapoport A; Mauskop A; Diener HC; Schwalen S; Pfeil J
Headache; 2006; 46(7):1151-60. PubMed ID: 16866719
[TBL] [Abstract][Full Text] [Related]
14. Topiramate as an adjunctive treatment in migraine prophylaxis.
Martínez HR; Londoño O; Cantú-Martínez L; del Carmen Tarín L; Castillo CD
Headache; 2003; 43(10):1080-4. PubMed ID: 14629243
[TBL] [Abstract][Full Text] [Related]
15. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
16. Open-label zonisamide for refractory migraine.
Drake ME; Greathouse NI; Renner JB; Armentbright AD
Clin Neuropharmacol; 2004; 27(6):278-80. PubMed ID: 15613932
[TBL] [Abstract][Full Text] [Related]
17. Topiramate in migraine prevention: results of a large controlled trial.
Silberstein SD; Neto W; Schmitt J; Jacobs D;
Arch Neurol; 2004 Apr; 61(4):490-5. PubMed ID: 15096395
[TBL] [Abstract][Full Text] [Related]
18. Topiramate in migraine prevention.
Silberstein SD
Headache; 2005 Apr; 45 Suppl 1():S57-65. PubMed ID: 15833091
[TBL] [Abstract][Full Text] [Related]
19. Topiramate for patients with refractory migraine: an observational, multicenter study in Spain.
Pascual J; Sánchez del Rio M; Mateos V; Láinez JM; Hernández-Gallego J; Leira R; Jiménez MD
Neurologia; 2003 Sep; 18(7):364-7. PubMed ID: 14505244
[TBL] [Abstract][Full Text] [Related]
20. Zonisamide for migraine prophylaxis in refractory patients.
Ashkenazi A; Benlifer A; Korenblit J; Silberstein SD
Cephalalgia; 2006 Oct; 26(10):1199-202. PubMed ID: 16961786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
